Dendrimer aggregates for biomolecule encapsulation and protection
Innovative dendrimer aggregates designed for the encapsulation and protection of biomolecules, offering non-toxic and substrate-agnostic solutions with shear-induced release capabilities.
Overview
Dendrimer aggregates developed by North Carolina State University provide a groundbreaking solution for the encapsulation and protection of sensitive biomolecules such as drug conjugates, bacteriophages, and proteins. These dendrimers are non-toxic and substrate agnostic, capable of engulfing a wide range of nanometer-scale objects at low concentrations. The innovative design ensures that payloads are stabilized within the dendrimer matrix and can be released through shear-induced methods, such as syringe filtration or other rheological-based techniques, providing a controlled release mechanism.
Technical specifications
Key features:
- Encapsulation capability: Efficiently encapsulates nanometer-scale objects, including various biomolecules.
- Controlled release: Payloads are released through shear-induced methods, ensuring precise delivery.
- Non-toxic and substrate agnostic: Safe for a variety of applications without substrate-specific limitations.
Technology readiness level
This technology is currently at TRL 4, having been demonstrated in several model systems. Further research aims to optimize encapsulation and release mechanisms for specific microbials and biomolecules of interest to potential partners.
About North Carolina State University
North Carolina State University is a large, comprehensive public land‑grant research university in Raleigh. Its on‑campus research and technology park co‑locates corporate R&D groups, government partners, and faculty labs, enabling shared facilities, prototyping, and agile contracting. Located in North Carolina’s Research Triangle, partners tap a dense regional ecosystem while engaging through a statewide extension network and a mature co‑op program that deliver field deployment and workforce pipelines. Multiple pilot and demonstration facilities support scale‑up and validation toward pre‑commercial readiness. Research is supported by competitive funding from major federal agencies, including NSF, USDA, DOE, and DOD, and a dedicated technology transfer office with clear IP pathways helps accelerate commercialization.
delivered to your inbox.